From: Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study
Non-LNM (n = 37) | LNM (n = 82) | P-value | |
---|---|---|---|
Tumor size (cm) | 4.44 ± 3.81 | 5.37 ± 2.54 | 0.120 |
Tumor size classification (n, %) | 0.062 | ||
< 5 cm | 27 (73.0%) | 45 (54.9%) | – |
≥ 5 cm | 10 (27.0%) | 37 (45.1%) | – |
G grade (n, %) | 0.210 | ||
G1 | 3 (8.3%) | 5 (6.1%) | – |
G2 | 0 (0.0%) | 4 (4.88%) | – |
G3 | 22 (61.1%) | 59 (72.0%) | – |
NEC | 11 (30.6%) | 14 (17.1%) | – |
Tumor location (n, %) | 0.005* | ||
Cardia and fundus of stomach | 16 (43.2%) | 46 (56.3%) | – |
Body of stomach | 9 (24.3%) | 30 (36.6%) | – |
Pyloric antrum | 7 (18.9%) | 5 (6.5%) | – |
Pyloric canal | 5 (13.5%) | 1 (1.2%) | – |
CD56 (n, %) | 0.177 | ||
– | 9 (27.3%) | 15 (21.9%) | – |
+ | 12 (36.4%) | 32 (46.4%) | – |
++ | 8 (24.2%) | 7 (10.1%) | – |
+++ | 4 (12.1%) | 15 (21.7%) | – |
Unknown | 4 (12.1%) | 13 (15.9%) | – |
Ki67 | 43.3 ± 27.6% | 58.3 ± 21.6% | 0.002* |
Syn (n, %) | 0.405 | ||
– | 0 | 1 (1.2%) | – |
+ | 14 (37.8%) | 22 (26.8%) | – |
++ | 5 (13.5%) | 20 (24.4%) | – |
+++ | 17 (45.9%) | 37 (45.1%) | – |
Unknown | 1 (2.7%) | 2 (2.4%) | – |
CgA (n, %) | 0.045* | ||
– | 9 (24.4%) | 22 (26.8%) | – |
+ | 14 (37.8%) | 31 (37.8%) | – |
++ | 0 | 11 (13.4%) | – |
+++ | 13 (35.1%) | 15 (18.3%) | – |
Unknown | 1 (2.7%) | 3 (3.7%) | – |